Is Srivari Spices & overvalued or undervalued?
As of August 14, 2025, Srivari Spices is considered overvalued with a valuation grade of expensive, reflected by a PE ratio of 14.11 and a significant 45.25% decline in stock performance over the past year, despite having a lower PE than peers like Hindustan Unilever and Nestle India.
As of 14 August 2025, the valuation grade for Srivari Spices & has moved from very expensive to expensive. The company is currently considered overvalued based on its financial ratios. The PE ratio stands at 14.11, while the EV to EBITDA ratio is 8.38, and the PEG ratio is 0.93, indicating a premium compared to its earnings growth potential.In comparison to its peers, Srivari Spices & has a lower PE ratio than Hindustan Unilever, which has a PE of 54.86, and Nestle India, which stands at 69.82. However, it is still positioned within an expensive range relative to other companies in the FMCG sector, such as Britannia Industries, which has a PE of 58.29. The recent performance of Srivari Spices & shows a significant decline of 45.25% over the past year, contrasting with a modest 2.02% gain in the Sensex, further reinforcing the notion of overvaluation.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
